BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12851680)

  • 1. Adenovirus-mediated inhibition of NF-kappaB confers chemo-sensitization and apoptosis in prostate cancer cells.
    Flynn V; Ramanitharan A; Moparty K; Davis R; Sikka S; Agrawal KC; Abdel-Mageed AB
    Int J Oncol; 2003 Aug; 23(2):317-23. PubMed ID: 12851680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF; Wang Y; Cho JY; Libermann TA
    Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis.
    Dong QG; Sclabas GM; Fujioka S; Schmidt C; Peng B; Wu T; Tsao MS; Evans DB; Abbruzzese JL; McDonnell TJ; Chiao PJ
    Oncogene; 2002 Sep; 21(42):6510-9. PubMed ID: 12226754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus-mediated IKKbetaKA expression sensitizes prostate carcinoma cells to TRAIL-induced apoptosis.
    Sanlioglu AD; Koksal IT; Karacay B; Baykara M; Luleci G; Sanlioglu S
    Cancer Gene Ther; 2006 Jan; 13(1):21-31. PubMed ID: 16052230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
    Huerta-Yepez S; Vega M; Garban H; Bonavida B
    Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-kappa B-mediated chemoresistance in breast cancer cells.
    Weldon CB; Burow ME; Rolfe KW; Clayton JL; Jaffe BM; Beckman BS
    Surgery; 2001 Aug; 130(2):143-50. PubMed ID: 11490342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo.
    Zhang M; Mukherjee N; Bermudez RS; Latham DE; Delaney MA; Zietman AL; Shipley WU; Chakravarti A
    Prostate; 2005 Aug; 64(3):293-302. PubMed ID: 15754318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
    Tse AK; Wan CK; Shen XL; Yang M; Fong WF
    Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel-induced apoptosis may occur without a prior G2/M-phase arrest.
    Dziadyk JM; Sui M; Zhu X; Fan W
    Anticancer Res; 2004; 24(1):27-36. PubMed ID: 15015572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of IkappaB kinase epsilon expression by the androgen receptor and the nuclear factor-kappaB transcription factor in prostate cancer.
    Péant B; Diallo JS; Lessard L; Delvoye N; Le Page C; Saad F; Mes-Masson AM
    Mol Cancer Res; 2007 Jan; 5(1):87-94. PubMed ID: 17259348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An essential role for nuclear factor kappa B in preventing TNF-alpha-induced cell death in prostate cancer cells.
    Sumitomo M; Tachibana M; Nakashima J; Murai M; Miyajima A; Kimura F; Hayakawa M; Nakamura H
    J Urol; 1999 Feb; 161(2):674-9. PubMed ID: 9915481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-kappaB activation in human prostate cancer: important mediator or epiphenomenon?
    Suh J; Rabson AB
    J Cell Biochem; 2004 Jan; 91(1):100-17. PubMed ID: 14689584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of androgen-independent prostate cancer PC-3 cells is associated with increased nuclear factor-kappaB activity.
    Floryk D; Huberman E
    Cancer Res; 2005 Dec; 65(24):11588-96. PubMed ID: 16357169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen-mediated resistance to apoptosis.
    Coffey RN; Watson RW; O'Neill AJ; Mc Eleny K; Fitzpatrick JM
    Prostate; 2002 Dec; 53(4):300-9. PubMed ID: 12430141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Id-1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells.
    Ling MT; Wang X; Ouyang XS; Xu K; Tsao SW; Wong YC
    Oncogene; 2003 Jul; 22(29):4498-508. PubMed ID: 12881706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation.
    Kukreja P; Abdel-Mageed AB; Mondal D; Liu K; Agrawal KC
    Cancer Res; 2005 Nov; 65(21):9891-8. PubMed ID: 16267013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells.
    Altuwaijri S; Lin HK; Chuang KH; Lin WJ; Yeh S; Hanchett LA; Rahman MM; Kang HY; Tsai MY; Zhang Y; Yang L; Chang C
    Cancer Res; 2003 Nov; 63(21):7106-12. PubMed ID: 14612503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling.
    Weldon CB; Parker AP; Patten D; Elliott S; Tang Y; Frigo DE; Dugan CM; Coakley EL; Butler NN; Clayton JL; Alam J; Curiel TJ; Beckman BS; Jaffe BM; Burow ME
    Int J Oncol; 2004 Jun; 24(6):1473-80. PubMed ID: 15138590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutively activated nuclear factor-kappaB, but not induced NF-kappaB, leads to TRAIL resistance by up-regulation of X-linked inhibitor of apoptosis protein in human cancer cells.
    Braeuer SJ; Büneker C; Mohr A; Zwacka RM
    Mol Cancer Res; 2006 Oct; 4(10):715-28. PubMed ID: 17050666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High selenium reduces NF-kappaB-regulated gene expression in uninduced human prostate cancer cells.
    Christensen MJ; Nartey ET; Hada AL; Legg RL; Barzee BR
    Nutr Cancer; 2007; 58(2):197-204. PubMed ID: 17640166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.